Jump to content

Talk:CD4+ T cells and antitumor immunity

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Wiki Education Foundation-supported course assignment

[edit]

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Immcarle45.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 16:29, 16 January 2022 (UTC)[reply]

Revision

[edit]

Sources for revision: Interleukins, from 1 to 37, and interferon-g: Receptors, functions, and roles in diseases (Akdis, J Allergy Clin Immunol, 2011, PMID 21377040) A cytokine-mediated link between innate immunity, inflammation, and cancer (Lin, J Clin Invest, 2007, PMC1857251) CD4 T-cell Subsets and Tumor Immunity: The helpful and the not-so-helpful (Kim, Cancer Immunol Res, PMID:24778273) Tumor antigen-specific T helper cells in cancer immunity and immunotherapy (Knutson, Cancer Immunol Immunother, 2005, PMID:16010587) Immunity, inflammation, and cancer: an eternal fight between good and evil (Shalapour, J Clin Invest, 2015, PMC:4588298) Expanding Roles for CD4 T Cells and their Subpopulations in Tumor Immunity and Therapy (Dobrzanski, Front Oncol, 2013, PMC:3607796)Immcarle45 (talk) 05:03, 8 February 2017 (UTC)[reply]

This page needs to be renamed to a more general name. Also major revision of format is necessary. -- Bubbachuck 06:53, 3 August 2007 (UTC)[reply]

This page should be merged with T-helper cells --- Bwthemoose/Talk 03:08, 20 November 2007 (UTC)[reply]

This page should NOT include a section on CD8+ T cells, if the title (focus is suppose to) CD4+T cells remain. Maybe it should be moved. Aqua112233 (talk) 10:11, 24 February 2011 (UTC)[reply]